Chat with us, powered by LiveChat


Hypodermic Syringes And Needles Market Report


Hypodermic Syringes and Needles Market by Type (Needles, Syringes and Combination) and Region (North America, Europe, Asia-Pacific, and LAMEA): Opportunity Analysis and Industry Forecast, 2023-2032


Pages: 375

Jul 2023

Hypodermic Syringes and Needles Overview

Hypodermic syringes and needles are medical devices utilized in the healthcare industry to manage medications, fluids, or other bodily substances. The syringe comprises an empty cylindrical tube with a cylinder at one end and a nozzle lock at the other. It is designed to draw and push fluids through the syringe. Needles are thin, hollow, metallic tubes attached to the syringe's nozzle or luer lock. They have sharp beveled tips for easy penetration of the skin or tissues. Syringes and needles come in several sizes and gauges, depending on the application. They are regularly utilized for infusions, permitting subcutaneous, intramuscular, or intravenous organization of drugs and antibodies. Additionally, they are used for procedures like blood collection and diagnostic sampling. It is crucial to ensure that trained healthcare professionals or individuals under their guidance use these devices to guarantee proper technique, sterility, and safety. Furthermore, adequate disposal of used needles is paramount to prevent accidental needlestick injuries and the transmission of bloodborne infections.

Global Hypodermic Syringes and Needles Market Analysis

The global hypodermic syringes and needles market size was $3,464.45 million in 2022 and is predicted to grow with a CAGR of 5.6% by generating a revenue of $5,833.09 million by 2032.

COVID-19 Impact on Global Hypodermic Syringes and Needles Market

The COVID-19 pandemic has impacted the global market for hypodermic syringes and needles. The urgent need for COVID-19 testing, vaccinations, and treatment drove the demand for these medical devices. Mass vaccination campaigns increased the demand for syringes and needles to administer vaccines, propelling the market growth. However, the pandemic brought new challenges, such as logistical challenges in vaccine distribution and disruptions in the global supply chain. Safety features in syringes and needles became more critical, and government initiatives to support production and distribution were implemented. Long-term implications include increased demand for these devices, advancements in safety features, and supply chain resilience.

Increase in Prevalence of Chronic Diseases to Drive the Market Growth

Several factors influence the hypodermic syringes and needles market. First, there is a greater need for these devices in administering medications and treatments due to the rise in prevalence of chronic diseases like diabetes, cancer, and cardiovascular disorders. The aging population, which demands ongoing medical attention and injections, also contributes to the market's growth. Additionally, the demand for hypodermic syringes and needles significantly increased by expanding vaccination programs, including routine vaccinations and emergency vaccination campaigns.

Safety features, needleless injection systems, and technological advancements in syringe and needle technology are essential in driving the market growth. Furthermore, rising healthcare expenditure, stricter regulations on needlestick injuries, increased awareness of infectious diseases, the expansion of healthcare facilities, the development of the home healthcare market, and the rise in medical tourism all contribute to the rising demand for hypodermic syringes and needles.

Contact our analysts here to learn more about global hypodermic syringes and needles market drivers.

Increasing Use of Alternative Drug Delivery Methods to Restrain the Market Growth

The factor limiting the growth of the hypodermic syringe needles market is the increased use of alternative drug delivery methods. Complex regulations and certifications are required to comply, which presents a significant hurdle for new entrants to enter the market. Additionally, the increasing use of alternative drug delivery methods such as transdermal patches and inhalers has reduced the need for hypodermic syringes and needles in some applications. Concerns about needlestick injuries have prompted the development of safety-engineered devices. However, their higher cost than standard options may limit their widespread adoption.

Cost constraints, particularly in resource-constrained settings, and the environmental impact of medical waste disposal are also challenges faced by the market. The market is also impacted by limited access to healthcare in specific regions and supply chain disruptions. Despite these constraints, the industry continues to innovate and address these issues through improved safety features, cost-effective solutions, and market-dynamic adaptation.

Increasing Healthcare Expenditure to Drive Excellent Opportunities

The hypodermic syringes and needles market offers considerable growth and development opportunities. Rising healthcare spending benefits the market globally, driven by population growth and the rising prevalence of chronic diseases. Technological advancements, such as safety mechanisms, precision-engineered needles, and intelligent features, open the door to improved and more efficient syringes and needles. The increasing demand for vaccines, therapeutics, and home healthcare raises the bar for dependable and secure delivery systems.

Syringes and needles are continuously in demand due to the growing elderly population's higher healthcare needs. The promotion of sterile and single-use devices is encouraged by the focus on safe injection techniques and growing awareness, which presents opportunities for manufacturers. Additionally, emerging markets with expanding healthcare spending and bettering healthcare infrastructure present promising growth opportunities. Market players should concentrate on product innovation, quality enhancement, cost-effectiveness, and customization to accommodate various healthcare settings and patient populations to take advantage of these opportunities.

Contact our analysts here to learn more about global hypodermic syringes and needles market opportunities.

Global Hypodermic Syringes and Needles Market Share, by Type, 2022

The needles sub-segment accounted for the highest market share in 2022. Needles have long been the primary product in the market for hypodermic syringes and needles. They are a crucial component of syringes that doctors and patients use to administer injections, draw blood samples, and administer medications intravenously. Depending on the patient's needs, needles can be used in various ways and are dependable and precise. They've been examined and found to be secure. Some needles have unique features to avoid mishaps like needlestick wounds. Needles are still the most popular and reliable tool for doctors and patients, even though there are newer methods of administering medication. They can be used for various medical treatments and are also reasonably priced. As a result, needles continue to dominate the market and are in high demand for vaccines, medications, and blood tests.

Global Hypodermic Syringes and Needles Market Size, by Region, 2022

The Asia-Pacific region has developed as a dominant force within the hypodermic syringes and needles market due to different components. Firstly, the region's huge populace, counting nations like China and India, has expanded demand for these medical devices. Furthermore, significant investments in healthcare infrastructure, such as hospitals and clinics, have fueled the requirement for syringes and needles. Thirdly, the increasing prevalence of chronic diseases like diabetes and heart conditions has driven the requirement of these devices. In addition, the region's economic growth has resulted in higher healthcare investing, including obtaining medical supplies like syringes and needles. Nations such as China and India have well-established manufacturing capabilities and talented labor, empowering them to deliver these devices productively. This has also positioned them as major exporters of medical devices.

Competitive Scenario in the Global Hypodermic Syringes and Needles Market

Product launch and technological advancement are common strategies followed by major market players. Some of the leading hypodermic syringes and needles market players are Smiths Medical, B. Braun Medical, Inc., BD, Cardinal Health, Terumo Corporation, Nipro Corporation, Lifelong Meditech Private Limited, EXELINT International, Co., Vitrex Medical A/S, and Retractable Technologies.



  Historical Market Estimations


  Base Year for Market Estimation


  Forecast Timeline for Market Projection


  Geographical Scope

  North America, Europe, Asia-Pacific, and LAMEA

  Segmentation by Type

  • Needles
  • Syringes
  • Combination

  Key Companies Profiled

  • Smith’s Medical
  • B. Braun Medical, Inc.
  • BD
  • Cardinal Health
  • Terumo Corporation
  • Nipro Corporation
  • Lifelong Meditech Private Limited
  • EXELINT International, Co.
  • Vitrex Medical A/S
  • Retractable Technologies

Frequently Asked Questions

A. The size of the global hypodermic syringes and needles market was over $3,464.45 million in 2022 and is projected to reach $5,833.09 million by 2032.

A. Smiths Medical and B. Braun Medical, Inc. are some of the key players in the hypodermic syringes and needles market.

A. The Asia-Pacific region possesses great investment opportunities for investors to witness the most promising growth in the future.

A. Product launch and technological advancement are the two key strategies opted by the operating companies in this market.

A. Smiths Medical and B. Braun Medical, Inc. are the companies investing more on R&D activities for developing new products and technologies.

Purchase Options

Personalize this research

  • Triangulate with your own data
  • Request your format and definition
  • Get a deeper dive on a specific application, geography, customer or competitor
10% Off on Customization
Contact Us

Customers Also Viewed